Research on a New Intelligent Mobile Screening and Diagnosis Pattern for Ocular Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

15000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-31

Study Completion Date

2029-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The global distribution of primary ophthalmic medical resources is uneven, and the traditional eye disease screening model has problems such as low efficiency, high cost and limited coverage. With the development of artificial intelligence and other technologies, it provides technical support for the construction of intelligent mobile screening model for eye diseases. The investigator's team has developed the 5G intelligent ophthalmic vehicle and served tens of thousands of people in 108 cities nationwide, initially verifying the feasibility of the new intelligent mobile screening model. However, the application effect, acceptance and influencing factors of this model in different regions are not clear, and there is a lack of economic benefit analysis based on real-world data. In this study, the investigators will conduct a cross-sectional study of large-scale population screening for blinding eye diseases in grassroots areas through the smart mobile screening model, focusing on the screening effectiveness and cost-effectiveness of the smart mobile screening model, integrating real-world multimodal eye health data, developing multiple smart screening analysis models, and exploring its adaptability and direction of improvement in grassroots areas.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dry Eye Screening and Referral System

NCT04413370

Dry Eye

UNKNOWN

Multi-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical Application

NCT03899623

Diabete Mellitus Diabetic Retinopathy

UNKNOWN

AI-Powered DIY Screening System for Diabetic Retinopathy

NCT06892353

Diabetic Retinopathy

RECRUITING NA

Real-world of AI in Diagnosing Retinal Diseases

NCT05981950

Artificial Intelligence Retinal Diseases

RECRUITING

AI Classifies Multi-Retinal Diseases

NCT04592068

Deep Learning Retinal Diseases

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ophthalmic Diseases (Specific Types Not Restricted) Cataract Refraction Error Diabetic Retinopathy (DR) Age Related Macular Degeneration (ARMD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intelligent Mobile Group

Participants were first screened for mobile eye health risk classification, and those who met the requirements were further screened by eye examination on the mobile clinic and suspected cases were recommended to be referred to higher level hospitals for consultation, and corresponding data were collected at different visit points.

No interventions assigned to this group